From Bench to Bedside, Faster
REPROCELL (reprocell.com) scores 79 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands, Other brands, in the 68th percentile of 16750 Healthcare brands.
REPROCELL is a drug discovery and stem cell research company headquartered in Yokohama, Japan, founded in 2003. It provides integrated preclinical and clinical research solutions, including donor sourcing, cell derivation, gene editing, and GMP manufacturing, to support the translation of stem cell and drug discovery research into therapies. The company serves cell therapy developers, stem cell researchers, diagnostic developers, and drug developers seeking human-relevant, reproducible research tools and data.
| Brand Name | REPROCELL |
|---|---|
| Domain | reprocell.com |
| Industry | Healthcare, SaaS |
| Founded | 2003 |
| Headquarters | Yokohama |
| Main Competitors | Lonza (86/100), Charles River Laboratories (69/100), STEMCELL Technologies (85/100), Thermo Fisher Scientific (90/100), FUJIFILM Cellular Dynamics (69/100), Evotec (88/100), Axol Bioscience (75/100), WuXi AppTec (85/100) |
Moz Domain Authority 43/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,150,392 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Stem cell and drug discovery scientists around the world use our solutions to translate their research in to therapies." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, og:title, og:description, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, HubSpot.
Social footprint: verified profiles on LinkedIn, YouTube, Instagram; no detected presence on X (Twitter), Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is REPROCELL?", Claude could identify the brand as of October 2026. REPROCELL is a biotechnology company specializing in stem cell technology and regenerative medicine tools, providing products like iPSCs (induced pluripotent stem cells), primary human tissues, and in vitro models used for drug discovery and toxicology testing. It serves pharmace Best known for Providing human-relevant stem cell and tissue-based models for drug discovery and toxicology research.
When asked "Best brands similar to REPROCELL?", Claude would recommend REPROCELL as of October 2026. It's a recognized player in the stem cell and in vitro model space for pharma research, so it would be relevant if discussing alternatives to companies offering human biological research tools.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
REPROCELL's main competitors in Healthcare: Lonza (86/100), Charles River Laboratories (69/100), STEMCELL Technologies (85/100), Thermo Fisher Scientific (90/100), FUJIFILM Cellular Dynamics (69/100).
Sources: Brand Analyzer scan
REPROCELL offers services including donor sourcing, cell derivation, gene editing, and GMP manufacturing of human cells. These are intended to provide high-quality, reproducible, and clinically relevant human cell-based tools and data for drug discovery and cell therapy development.
Sources: REPROCELL official site
REPROCELL is a drug discovery and stem cell research company based in Yokohama, Japan, founded in 2003. It develops integrated preclinical and clinical research solutions designed to help translate stem cell and drug discovery research into therapies.
Sources: REPROCELL official site
REPROCELL has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 46, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: REPROCELL official site
REPROCELL was founded in 2003. REPROCELL operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
REPROCELL is headquartered in Yokohama. REPROCELL operates in the Healthcare category.
Sources: Wikidata
REPROCELL provides end-to-end, regulatory-aligned research solutions for stem cell and drug discovery work. Its services span donor sourcing, cell derivation, gene editing, and GMP manufacturing, producing human cells and associated data intended to support and de-risk drug and cell therapy development for researchers and developers worldwide.
Sources: REPROCELL official site
REPROCELL scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: REPROCELL official site
REPROCELL can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: REPROCELL official site
REPROCELL's solutions are used by cell therapy developers, stem cell researchers, diagnostic developers, and preclinical and clinical drug developers who require reliable, human-relevant research materials and data to support therapy development.
Sources: REPROCELL official site
REPROCELL is known for offering integrated, end-to-end solutions that connect preclinical stem cell research with clinical drug and cell therapy development, including services such as donor sourcing, cell derivation, gene editing, and GMP manufacturing of human cells.
Sources: REPROCELL official site
REPROCELL scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
REPROCELL has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,150,392 (Tranco) and a Moz Domain Authority of 43/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify REPROCELL from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to REPROCELL: Remedi SeniorCare (79/100), Relatient (79/100), Organization for Autism Research (OAR) (79/100), CooperSurgical (79/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.